Table 1 Methods and endpoints in the RE-AIM framework
Quantative study endpoints: HCV care pathway (part 1) | RE-AIM dimensiona | Qualitative study endpoints: barriers and facilitators (part 2) |
|---|---|---|
• Demographics of population • Proportion of population tested | Reach | • Individual reasons for not participating • Recruitment of patients • Willingness to participate |
• Viral elimination rate | Effectiveness | – |
• Proportion of centers participating | Adoption | • Willingness to initiate the program |
• Secondary HCV care endpoints (treatment uptake, completion) • Referral to hospital • Loss to follow up • Adherence | Implementation | • Strategies to improve implementation |